Newsletter | July 30, 2025

Best of July 2025: Top 5 Insights In Clinical Trial Technology

Clinical Tech Leader

TOP 5 INSIGHTS IN CLINICAL TRIAL TECHNOLOGY
JULY EDITION

#1 - The Placeholder Debate: Why Teams Love (And Hate) This TMF Tool

This article takes a closer look at what placeholders are, how they work, and why they continue to be a source of both value and frustration. If your team is weighing whether or not to use them — or just wants to better understand the trade-offs — this is for you.

#2 - Artificial Intelligence And Machine Learning In Pharmacovigilance: Unlocking Potential To Drive Innovation In Patient Safety

Explore how artificial intelligence (AI) and machine learning (ML) hold transformative potential in pharmacovigilance (PV), with the ability to enhance the efficiency, accuracy, and timeliness of drug safety monitoring.

#3 - Tufts & PACT Release New DCT Analysis

take a closer look at some of the key stats in a new DCT report from the Partnership for Advancing Clinical Trials (PACT), a consortium hosted and facilitated by the Tufts Center for the Study of Drug Development (CSDD).

#4 - Productivity Hacks For An Effective RFP / Clinical Trial Vendor Selection

Starting a new clinical study requires careful vendor selection. Use these practical, actionable steps to enhance your selection process and ensure long-term partnership alignment.

#5 - Paving The Way For Sites To Use Their Own Tech

The DTRA has released a detailed playbook to help clinical research sites use their own validated technology in sponsor-led trials. Learn how the "Bring Your Own Technology" (BYOT) model aims to reduce tech overload at sites, improve efficiency, and preserve regulatory compliance — starting with eConsent as its first use case.